Why the study?
Does low dose colchicine reduce expression of inflammatory markers in patients with coronary atherosclerotic plaque?
Does low dose colchicine reduce expression of inflammatory markers in patients with coronary atherosclerotic plaque?
Answers are grounded in this paper and cite their sources.
Low-dose colchicine may rapidly reduce local inflammation in coronary atherosclerotic plaques, supporting its potential role in acute coronary syndromes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Nidorf et al. (2015) conducted an editorial in Acute Coronary Syndromes. Colchicine was evaluated on Expression of inflammatory markers (IL-1ß and IL-18).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: